Effects on lipids and pharmacokinetics parameters of PCSK9 mabs in a real life setting high CV risk patients. (August 2022) - Trevisin, M.; Zambon, A.; Zambon, S.; Giammanco, A.; Cefalù, A.B.; Averna, M.; Lupo, M.G.; Ferri, N.